Accounts Payable

$1.16B

Quarterly · Period ending: Jun 30, 2026 · USD

REGN Accounts Payable

Latest reported$1.16Bperiod endingJun 30, 2026

REGN Quarterly Accounts Payable ($0.00 → $1.16B)

Quarterly accounts payable

High-resolution chart · PNG

REGN accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Accounts Payable — Quarterly (USD)
Period ending	Accounts Payable (USD)
Jun 30, 2026	1,159,300,000
Mar 31, 2026	1,027,100,000
Dec 31, 2025	939,000,000
Sep 30, 2025	903,800,000
Jun 30, 2025	723,900,000
Mar 31, 2025	705,500,000
Dec 31, 2024	789,500,000
Sep 30, 2024	497,300,000
Jun 30, 2024	561,700,000
Mar 31, 2024	671,300,000
Dec 31, 2023	606,600,000
Sep 30, 2023	536,600,000
Jun 30, 2023	547,300,000
Mar 31, 2023	599,500,000
Dec 31, 2022	589,200,000
Sep 30, 2022	535,600,000
Jun 30, 2022	534,200,000
Mar 31, 2022	470,300,000
Dec 31, 2021	564,000,000
Sep 30, 2021	427,000,000
Jun 30, 2021	476,000,000
Mar 31, 2021	542,900,000
Dec 31, 2020	475,500,000
Sep 30, 2020	443,100,000
Jun 30, 2020	380,100,000
Mar 31, 2020	347,800,000
Dec 31, 2019	418,100,000
Sep 30, 2019	335,600,000
Jun 30, 2019	244,000,000
Mar 31, 2019	239,600,000
Dec 31, 2018	218,200,000
Sep 30, 2018	172,361,000
Jun 30, 2018	171,906,000
Mar 31, 2018	207,611,000
Dec 31, 2017	178,200,000
Sep 30, 2017	153,946,000
Jun 30, 2017	151,372,000
Mar 31, 2017	141,801,000
Dec 31, 2016	134,984,000
Sep 30, 2016	124,497,000
Jun 30, 2016	101,721,000
Mar 31, 2016	120,595,000
Dec 31, 2015	140,962,000
Sep 30, 2015	106,917,000
Jun 30, 2015	130,016,000
Mar 31, 2015	90,601,000
Dec 31, 2014	99,508,000
Sep 30, 2014	47,342,000
Jun 30, 2014	47,231,000
Mar 31, 2014	32,692,000
Dec 31, 2013	61,936,000
Sep 30, 2013	31,194,000
Jun 30, 2013	24,418,000
Mar 31, 2013	24,729,000
Dec 31, 2012	38,934,000
Sep 30, 2012	21,943,000
Jun 30, 2012	25,672,000
Mar 31, 2012	25,390,000
Dec 31, 2011	27,736,000
Sep 30, 2011	17,309,000
Jun 30, 2011	25,955,000
Mar 31, 2011	16,146,000
Dec 31, 2010	15,589,000
Sep 30, 2010	0
Jun 30, 2010	0
Mar 31, 2010	-136,188,000
Dec 31, 2009	18,638,000
Sep 30, 2009	0
Jun 30, 2009	13,034,000
Mar 31, 2009	17,779,000
Dec 31, 2008	6,268,000
Sep 30, 2008	13,188,000
Jun 30, 2008	10,436,000
Mar 31, 2008	9,475,000
Dec 31, 2007	8,128,000
Sep 30, 2007	5,330,000
Jun 30, 2007	18,546,000
Mar 31, 2007	4,805,000
Dec 31, 2006	21,471,000
Sep 30, 2006	3,657,000
Jun 30, 2006	2,840,000
Mar 31, 2006	3,758,000
Dec 31, 2005	4,203,000
Sep 30, 2005	20,599,000
Jun 30, 2005	17,043,000
Mar 31, 2005	17,468,000
Dec 31, 2004	18,872,000
Sep 30, 2004	20,284,000
Jun 30, 2004	15,743,000
Mar 31, 2004	18,947,000
Dec 31, 2003	18,933,000
Sep 30, 2003	20,967,000
Jun 30, 2003	14,043,000
Mar 31, 2003	25,201,000
Dec 31, 2002	30,309,000
Sep 30, 2002	24,376,000
Jun 30, 2002	16,933,000
Mar 31, 2002	17,068,000
Dec 31, 2001	14,830,000
Sep 30, 2001	10,120,000